← All Sponsors
SPONSOR

Indapta Therapeutics, INC.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2

Indapta Therapeutics, INC. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including NHL, Multiple Myeloma, Blood Cancer, Refractory Non-Hodgkin Lymphoma.

The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Indapta Therapeutics, INC.

How many clinical trials has Indapta Therapeutics, INC. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Indapta Therapeutics, INC., of which 1 are actively recruiting participants. These trials cover conditions including NHL, Multiple Myeloma, Blood Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Indapta Therapeutics, INC. research focus on?
Indapta Therapeutics, INC. clinical trials span NHL, Multiple Myeloma, Blood Cancer, Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Indapta Therapeutics, INC. clinical trial?
To participate in a Indapta Therapeutics, INC. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Indapta Therapeutics, INC. trials with current recruitment status updated daily.

Clinical Trials by Indapta Therapeutics, INC.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology